PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical can... PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.13 | 8.60927152318 | 1.51 | 1.72 | 1.4134 | 127056 | 1.55148603 | CS |
4 | -0.09 | -5.20231213873 | 1.73 | 1.8299 | 1.302 | 216380 | 1.54138661 | CS |
12 | -1.67 | -50.4531722054 | 3.31 | 3.405 | 1.302 | 392869 | 2.02236226 | CS |
26 | -1.83 | -52.7377521614 | 3.47 | 4.29 | 1.302 | 341026 | 2.68675341 | CS |
52 | -3.94 | -70.6093189964 | 5.58 | 6.68 | 1.302 | 544906 | 3.64266284 | CS |
156 | -3.6 | -68.7022900763 | 5.24 | 13.65 | 1.302 | 570089 | 5.4512724 | CS |
260 | -1.04 | -38.8059701493 | 2.68 | 17.85 | 0.61 | 729085 | 5.46598051 | CS |
Symbole | Prix | Vol. |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0,764 (321,87%) | 729,72M |
NVDANVIDIA Corporation | US$ 120,07 (-3,67%) | 388,54M |
RIMEAlgorhythm Holdings Inc | US$ 0,02565 (5,12%) | 338,75M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0,0355 (-11,25%) | 236,29M |
CLEUChina Liberal Education Holdings Ltd | US$ 0,1938 (30,77%) | 234,8M |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales